Concepedia

Garrett W. Rhyasen

GW

Statistics

Publications

7

Citations

636

H-Index

7

Active since

2012

Affiliations

Cincinnati Children's Hospital Medical Center(Current)

University of Cincinnati

Azienda ospedaliera "Bianchi-Melacrino-Morelli"

The University of Texas MD Anderson Cancer Center

University of Milan

Garrett W. Rhyasen is an author at Cincinnati Children's Hospital Medical Center specializing in molecular oncology, medicine, and oncology.

Publications per year

2012–2020

7

Publications

7

Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome

Garrett W. Rhyasen, Lyndsey Bolanos, Jing Fang et al. · Cancer Cell · 2013 · 201 citations · Full text

, , +7

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao et al. · Molecular Cancer Therapeutics · 2016 · 157 citations · Full text

, , +17

Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1

Jing Fang, Garrett W. Rhyasen, Lyndsey Bolanos et al. · Blood · 2012 · 102 citations · Full text

, , +16

OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues

Mark Wunderlich, Ryan A. Brooks, Rushi Panchal et al. · Blood · 2014 · 73 citations · Full text

, , +9

BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors

Garrett W. Rhyasen, Yi Yao, Jingwen Zhang et al. · PLoS ONE · 2018 · 54 citations · Full text

, , +17

1–5 of 7